An immunocytometric assay based on dengue infection via DC-SIGN permits rapid measurement of anti-dengue neutralizing antibodies

Journal of Virological Methods

Volumn 134, Issue 1-2, 2006, Pages 74-85

  Martin, Nicole C ^a,d   Pardo, Jorge ^a   Simmons, Monika ^a   Tjaden, Jeffrey A ^a   Widjaja, Susana ^c   Marovich, Mary A ^b   Sun, Wellington ^b   Porter, Kevin R ^a,d   Burgess, Timothy H ^a,d  

^a NAVAL MEDICAL RESEARCH CENTER   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^c US Naval Medical Research Unit No 2 Jakarta   (Indonesia)

^d UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

DC SIGN; Dengue antibodies; Dengue virus; Immunocytofluorimetry; Neutralization; PRNT

Indexed keywords

ANTISERUM; CD209 ANTIGEN; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROTYPE; VIRUS ISOLATION; VIRUS NEUTRALIZATION; VIRUS STRAIN;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; CELL ADHESION MOLECULES; CELL LINE, TUMOR; DENGUE; DENGUE VIRUS; FLOW CYTOMETRY; HUMANS; LECTINS, C-TYPE; MICE; NEUTRALIZATION TESTS; RECEPTORS, CELL SURFACE;

DENGUE VIRUS GROUP;

EID: 33646124476     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2005.12.002     Document Type: Article

References (32)

1. Blaney Jr. J.E., Matro J.M., Murphy B.R., and Whitehead S.S. Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys. J. Virol. 79 (2005) 5516-5528
2. Darden J.M., Polonis V.R., deSouza M.S., Chantakulkij S., Brown A.E., Birx D.L., and Pattanapanyasat K. A flow cytometric method for measuring neutralization of HIV-1 subtype B and E primary isolates. Cytometry 40 (2000) 141-150
3. Della-Porta A.J., and Westaway E.G. A multi-hit model for the neutralization of animal viruses. J. Gen. Virol. 38 (1978) 1-19
4. Diamond M.S., Edgil D., Roberts T.G., Lu B., and Harris E. Infection of human cells by dengue virus is modulated by different cell types and viral strains. J. Virol. 74 (2000) 7814-7823
5. Dimmock N.J. Neutralization of animal viruses. Curr. Top. Microbiol. Immunol. 183 (1993) 1-149
6. Dulbecco R., Vogt M., and Strickland A.G. A study of the basic aspects of neutralization of two animal viruses, western equine encephalitis virus and poliomyelitis virus. Virology 2 (1956) 162-205
7. Endy T.P., Nisalak A., Chunsuttitwat S., Vaughn D.W., Green S., Ennis F.A., Rothman A.L., and Libraty D.H. Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand. J. Infect. Dis. 189 (2004) 990-1000
8. Geijtenbeek T.B., Kwon D.S., Torensma R., van Vliet S.J., van Duijnhoven G.C., Middel J., Cornelissen I.L., Nottet H.S., KewalRamani V.N., Littman D.R., Figdor C.G., and van Kooyk Y. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100 (2000) 587-597
9. Guirakhoo F., Pugachev K., Zhang Z., Myers G., Levenbook I., Draper K., Lang J., Ocran S., Mitchell F., Parsons M., Brown N., Brandler S., Fournier C., Barrere B., Rizvi F., Travassos A., Nichols R., Trent D., and Monath T. Safety and efficacy of chimeric yellow Fever-dengue virus tetravalent vaccine formulations in nonhuman primates. J. Virol. 78 (2004) 4761-4775
10. Henchal E.A., Gentry M.K., McCown J.M., and Brandt W.E. Dengue virus-specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence. Am. J. Trop. Med. Hyg. 31 (1982) 830-836
11. Henchal E.A., Henchal L.S., and Schlesinger J.J. Synergistic interactions of anti-NS1 monoclonal antibodies protect passively immunized mice from lethal challenge with dengue 2 virus. J. Gen. Virol. 69 (1988) 2101-2107
12. Jirakanjanakit N., Sanohsomneing T., Yoksan S., and Bhamarapravati N. The micro-focus reduction neutralization test for determining dengue and Japanese encephalitis neutralizing antibodies in volunteers vaccinated against dengue. Trans. R. Soc. Trop. Med. Hyg. 91 (1997) 614-617
13. Kaufman B.M., Summers P.L., Dubois D.R., Cohen W.H., Gentry M.K., Timchak R.L., Burke D.S., and Eckels K.H. Monoclonal antibodies for dengue virus prM glycoprotein protect mice against lethal dengue infection. Am. J. Trop. Med. Hyg. 41 (1989) 576-580
14. Kaufman B.M., Summers P.L., Dubois D.R., and Eckels K.H. Monoclonal antibodies against dengue 2 virus E-glycoprotein protect mice against lethal dengue infection. Am. J. Trop. Med. Hyg. 36 (1987) 427-434
15. Kliks S.C., Nimmanitya S., Nisalak A., and Burke D.S. Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am. J. Trop. Med. Hyg. 38 (1988) 411-419
16. Lambeth C.R., White L.J., Johnston R.E., and de Silva A.M. Flow cytometry-based assay for titrating dengue virus. J. Clin. Microbiol. 43 (2005) 3267-3272
17. Mandel B. Neutralization of animal viruses. Adv. Virus Res. 23 (1978) 205-268
18. Mascola J.R., Louder M.K., Winter C., Prabhakara R., De Rosa S.C., Douek D.C., Hill B.J., Gabuzda D., and Roederer M. Human immunodeficiency virus type 1 neutralization measured by flow cytometric quantitation of single-round infection of primary human T cells. J. Virol. 76 (2002) 4810-4821
19. Morens D.M., Halstead S.B., Repik P.M., Putvatana R., and Raybourne N. Simplified plaque reduction neutralization assay for dengue viruses by semimicro methods in BHK-21 cells: comparison of the BHK suspension test with standard plaque reduction neutralization. J. Clin. Microbiol. 22 (1985) 250-254
20. Parren P.W., and Burton D.R. The antiviral activity of antibodies in vitro and in vivo. Adv. Immunol. 77 (2001) 195-262
21. Polack F.P., Hoffman S.J., Crujeiras G., and Griffin D.E. A role for nonprotective complement-fixing antibodies with low avidity for measles virus in atypical measles. Nat. Med. 9 (2003) 1209-1213
22. Porter K.R., Beckett C.G., Kosasih H., Tan R.I., Alisjahbana B., Rudiman P.I., Widjaja S., Listiyaningsih E., Ma'Roef C.N., McArdle J.L., Parwati I., Sudjana P., Jusuf H., Yuwono D., and Wuryadi S. Epidemiology of dengue and dengue hemorrhagic fever in a cohort of adults living in Bandung, West Java, Indonesia. Am. J. Trop. Med. Hyg. 72 (2005) 60-66
23. Rao B.L. Plaque formation of dengue viruses in Vero cell culture under carboxymethylcellulose overlay. Indian J. Med. Res. 64 (1976) 1709-1712
24. Russell P.K., and Nisalak A. Dengue virus identification by the plaque reduction neutralization test. J. Immunol. 99 (1967) 291-296
25. Russell P.K., Nisalak A., Sukhavachana P., and Vivona S. A plaque reduction test for dengue virus neutralizing antibodies. J. Immunol. 99 (1967) 285-290
26. Spouge J.L. Viral multiplicity of attachment and its implications for human immunodeficiency virus therapies. J. Virol. 68 (1994) 1782-1789
27. Sydow F.F., Santiago M.A., Neves-Souza P.C., Cerqueira D.I., Gouvea A.S., Lavatori M.F., Bertho A.L., and Kubelka C.F. Comparison of dengue infection in human mononuclear leukocytes with mosquito C6/36 and mammalian Vero cells using flow cytometry to detect virus antigen. Membr. Inst. Oswaldo. Cruz. 95 (2000) 483-489
28. Tassaneetrithep B., Burgess T.H., Granelli-Piperno A., Trumpfheller C., Finke J., Sun W., Eller M.A., Pattanapanyasat K., Sarasombath S., Birx D.L., Steinman R.M., Schlesinger S., and Marovich M.A. DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J. Exp. Med. 197 (2003) 823-829
29. Vorndam V., and Beltran M. Enzyme-linked immunosorbent assay-format microneutralization test for dengue viruses. Am. J. Trop. Med. Hyg. 66 (2002) 208-212
30. WHO, April 2002. Dengue and Dengue Haemorrhagic Fever. World Health Organization Fact Sheet No. 117.
31. Wu L., Martin T.D., Carrington M., and KewalRamani V.N. Raji B cells, misidentified as THP-1 cells, stimulate DC-SIGN-mediated HIV transmission. Virology 318 (2004) 17-23
32. Wu S.J., Grouard-Vogel G., Sun W., Mascola J.R., Brachtel E., Putvatana R., Louder M.K., Filgueira L., Marovich M.A., Wong H.K., Blauvelt A., Murphy G.S., Robb M.L., Innes B.L., Birx D.L., Hayes C.G., and Frankel S.S. Human skin Langerhans cells are targets of dengue virus infection. Nat. Med. 6 (2000) 816-820